Response to: Comment on “First-Line Helicobacter pylori Eradication with Vonoprazan, Clarithromycin, and Metronidazole in Patients Allergic to Penicillin”

• Soichiro Sue,
• Nobumi Suzuki,
• Wataru Shibata,
• Tomohiko Sasaki,
• Hiroaki Yamada,
• Hiroaki Kaneko,
• Toshihide Tamura,
• Tomohiro Ishii,
• Masaaki Kondo,
• Shin Maeda

Affiliations

Soichiro Sue

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Nobumi Suzuki

Department of Gastroenterology, Institute for Adult Disease, Asahi Life Foundation, Tokyo, Japan

Wataru Shibata

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Tomohiko Sasaki

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Hiroaki Yamada

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Hiroaki Kaneko

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Toshihide Tamura

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Tomohiro Ishii

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Masaaki Kondo

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Shin Maeda

Department of Gastroenterology, Yokohama City University Graduate School of Medicine, Yokohama, Japan